{"id":57487,"date":"2016-03-28T13:21:02","date_gmt":"2016-03-28T13:21:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=57487"},"modified":"2016-03-28T13:21:02","modified_gmt":"2016-03-28T13:21:02","slug":"japan-diabetes-market-an-insight-into-the-oral-antidiabetics-insulin-and-diabetes-diagnostics-market-in-japan","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/japan-diabetes-market-an-insight-into-the-oral-antidiabetics-insulin-and-diabetes-diagnostics-market-in-japan_57487.html","title":{"rendered":"Japan Diabetes Market &#8211; An Insight into the Oral Antidiabetics, Insulin and Diabetes Diagnostics Market in Japan"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.getnews.info\/wp-content\/uploads\/2016\/03\/a1459165739.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.getnews.info\/wp-content\/uploads\/2016\/03\/a1459165739.jpeg\" alt=\"\" width=\"225\" height=\"287\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">This new report from IMARC Group provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. This study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japanese diabetes market.<\/div>\n<p style=\"text-align: justify;\">IMARC&rsquo;s new report <strong>&ldquo;Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics&rdquo;<\/strong> provides an analytical and statistical insight into the <a rel=\"nofollow\" title=\"Japanese diabetes market\" href=\"http:\/\/www.imarcgroup.com\/japan-diabetes-market\" target=\"_blank\">Japanese diabetes market<\/a>. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japanese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japanese diabetes market in any form.<\/p>\n<p style=\"text-align: justify;\"><strong>What we have achieved in this report:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Focus of the Analysis:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Historical, current and future prevalence of diabetes in Japan<\/li>\n<li>Historical, current and future prevalence of type-1 and type-2 diabetes in Japan<\/li>\n<li>Historical, current and future prevalence of diabetes in the urban and rural regions in Japan<\/li>\n<li>Historical, current and future prevalence of diabetes among males and females in Japan<\/li>\n<li>Historical, current and future prevalence of diabetes among various age groups in Japan<\/li>\n<li>Historical, current and future diagnosis rates for diabetes in Japan<\/li>\n<li>Historical, current and future drug treatment rates for diabetes in Japan <\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><br \/>Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Focus of the Analysis:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Performance of the Oral Antidiabetics market in Japan<\/li>\n<li>Performance of key classes<\/li>\n<li>Performance of key players<\/li>\n<li>Market outlook<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><br \/>Comprehensive situation analysis of the Japanese Insulin market and its dynamics:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Focus of the Analysis:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Performance of the Insulin market in Japan<\/li>\n<li>Performance of key classes<\/li>\n<li>Performance of key players<\/li>\n<li>Market outlook<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><br \/>Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Focus of the Analysis:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Performance of the diabetes diagnostics market in Japan<\/li>\n<li>Market Segmentation<\/li>\n<li>Key players<\/li>\n<li>Market outlook <\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><br \/>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>1 Research Methodology<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>2 Executive Summary<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3 Diabetes Disease Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">3.1 What is Diabetes?<\/p>\n<p style=\"text-align: justify;\">3.2 Diabetes Diagnosis and Treatment<\/p>\n<p style=\"text-align: justify;\">3.2.1 Diagnosis<\/p>\n<p style=\"text-align: justify;\">3.2.2 Treatment<\/p>\n<p style=\"text-align: justify;\">3.3 Diabetes Complications<\/p>\n<p style=\"text-align: justify;\"><strong>4 Key Factors Driving the Diabetes Market in Japan<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>5 Japan Diabetes Epidemiology<\/strong><\/p>\n<p style=\"text-align: justify;\">5.1 Diabetes Population and Prevalence Rates<\/p>\n<p style=\"text-align: justify;\">5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)<\/p>\n<p style=\"text-align: justify;\">5.3 Population and Prevalence Rates by Region<\/p>\n<p style=\"text-align: justify;\">5.4 Population and Prevalence Rates by Gender<\/p>\n<p style=\"text-align: justify;\">5.5 Population and Prevalence Rates by Age Group<\/p>\n<p style=\"text-align: justify;\">5.6 Diabetes Diagnosis and Drug Treatment Rates<\/p>\n<p style=\"text-align: justify;\"><strong>6 Japan Diabetes Market<\/strong><\/p>\n<p style=\"text-align: justify;\">6.1 Historical Market Trends<\/p>\n<p style=\"text-align: justify;\">6.2 Market Outlook<\/p>\n<p style=\"text-align: justify;\">6.3 Market Breakup by Segment<\/p>\n<p style=\"text-align: justify;\">6.4 Japan Oral Antidiabetics Market<\/p>\n<p style=\"text-align: justify;\">6.4.1 Historical Market Trends<\/p>\n<p style=\"text-align: justify;\">6.4.2 Market Breakup by Class<\/p>\n<p style=\"text-align: justify;\">6.4.3 Market Shares of Key Players<\/p>\n<p style=\"text-align: justify;\">6.4.4 Market Outlook<\/p>\n<p style=\"text-align: justify;\">6.5 Japan Insulin Market<\/p>\n<p style=\"text-align: justify;\">6.5.1 Historical Market Trends<\/p>\n<p style=\"text-align: justify;\">6.5.2 Market Breakup by Class<\/p>\n<p style=\"text-align: justify;\">6.5.3 Market Shares of Key Players<\/p>\n<p style=\"text-align: justify;\">6.5.4 Market Outlook<\/p>\n<p style=\"text-align: justify;\"><strong>7 Japan Diabetes Diagnostics Market<\/strong><\/p>\n<p style=\"text-align: justify;\">7.1 Historical Market Trends<\/p>\n<p style=\"text-align: justify;\">7.2 Market Segmentation<\/p>\n<p style=\"text-align: justify;\">7.1 Key Players<\/p>\n<p style=\"text-align: justify;\"><strong>List of Figures<\/strong><\/p>\n<p style=\"text-align: justify;\">Figure 3 1: The impact of Diabetes in the Human Body<\/p>\n<p style=\"text-align: justify;\">Figure 3 2: Diabetes Complications<\/p>\n<p style=\"text-align: justify;\">Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 &amp; 2035<\/p>\n<p style=\"text-align: justify;\">Figure 4 2: Japan: Overweight &amp; Obese Population* (in Million), 2010, 2015. 2020<\/p>\n<p style=\"text-align: justify;\">Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes<\/p>\n<p style=\"text-align: justify;\">Figure 4 4: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 &amp; 65+), (in %),<\/p>\n<p style=\"text-align: justify;\">Figure 4 5 : Japan: Diabetes Prevalence By Age Groups, (in %),<\/p>\n<p style=\"text-align: justify;\">Figure 5 1: Japan: Total Number of Diabetes Patients* (in 000), 2008-2015<\/p>\n<p style=\"text-align: justify;\">Figure 5 2: Japan: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020<\/p>\n<p style=\"text-align: justify;\">Figure 5 3: Japan (Type1 &amp; Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015<\/p>\n<p style=\"text-align: justify;\">Figure 5 4: India (Type1 &amp; Type2): Total Number of Diabetes Patients* (in 000),2016-2020<\/p>\n<p style=\"text-align: justify;\">Figure 5 5: Japan (Urban &amp; Rural): Total Number of Diabetes Patients* (in 000), 2008 &#8211;&nbsp; 2015<\/p>\n<p style=\"text-align: justify;\">Figure 5 6: Japan (Urban &amp; Rural): Total Number of Diabetes Patients* (in 000), 2016 &ndash; 2020<\/p>\n<p style=\"text-align: justify;\">Figure 5 7: Japan (Male &amp; Female): Total Number of Diabetes Patients* (in 000), 2008 &#8211;&nbsp; 2015<\/p>\n<p style=\"text-align: justify;\">Figure 5 8: Japan (Male &amp; Female): Total Number of Diabetes Patients* (in 000), 2016 &ndash; 2020<\/p>\n<p style=\"text-align: justify;\">Figure 5 9: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) &amp; (60-79) (in 000), 2008 &#8211; 2015<\/p>\n<p style=\"text-align: justify;\">Figure 5 10: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) &amp; (60-79) (in 000), 2016 &ndash; 2020<\/p>\n<p style=\"text-align: justify;\">Figure 6 1: Japan: Diabetes Drugs Market (in Million US$), 2008-2015<\/p>\n<p style=\"text-align: justify;\">Figure 6 2: Japan: Diabetes Drug Market Forecast (in Million US$), 2016-2020<\/p>\n<p style=\"text-align: justify;\">Figure 6 3: Japan: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016-2020<\/p>\n<p style=\"text-align: justify;\">Figure 6 4: Japan: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008-2015<\/p>\n<p style=\"text-align: justify;\">Figure 6 5: Japan: Oral Antidiabetics Market: (in Million US$), 2008-2015<\/p>\n<p style=\"text-align: justify;\">Figure 6 6: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008&amp;2015<\/p>\n<p style=\"text-align: justify;\">Figure 6 7: India: Oral Anti-diabetics Market: Sales Share of Key Players (in %),<\/p>\n<p style=\"text-align: justify;\">Figure 6 8: Japan: Oral Antidiabetics Market: (in Million US$), 2016-2020<\/p>\n<p style=\"text-align: justify;\">Figure 6 9: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 &amp;2020<\/p>\n<p style=\"text-align: justify;\">Figure 6 10: Japan: Insulin Market, (in Million US$), 2008-2015<\/p>\n<p style=\"text-align: justify;\">Figure 6 11: Japan: Breakup of Insulin Market by Class (in %)<\/p>\n<p style=\"text-align: justify;\">Figure 6 12: Japan: Insulin Market: Sales Share of Key Players (in %)<\/p>\n<p style=\"text-align: justify;\">Figure 6 13: Japan: Insulin Market Forecast (in Million US$), 2016-2020<\/p>\n<p style=\"text-align: justify;\">Figure 7 1: Japan: Diabetes Diagnostics Market (in Million US$), 2008-2015<\/p>\n<p style=\"text-align: justify;\">Figure 7 2: Japan: Diabetes Diagnostics Market: Sales by Segment (in %)<\/p>\n<p style=\"text-align: justify;\">Figure 7 3: Japan: Diabetes Diagnostics Market Forecast (in Million US$), 2016-2020<\/p>\n<p style=\"text-align: justify;\"><strong>List of Tables<\/strong><\/p>\n<p style=\"text-align: justify;\">Table 3 1: Diagnosis of Diabetes<\/p>\n<p style=\"text-align: justify;\">Table 4 1: Global: Diabetes Population Breakup by Country (in 000&rsquo;s), 2015 &amp; 2035<\/p>\n<p style=\"text-align: justify;\">Table 4 2: Japan: Overweight &amp;Obesity Statistics, 2010, 2015 &amp; 2020<\/p>\n<p style=\"text-align: justify;\">Table 4 3: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 &amp; 65+), (in Million),<\/p>\n<p style=\"text-align: justify;\">Table 5 1: Japan: Total Prevalence &amp;Number of Diabetes Patients*, 2008, 2015 &amp; 2020<\/p>\n<p style=\"text-align: justify;\">Table 5 2: Japan (Type1 &amp; Type2): Total Prevalence &amp; Number of Diabetes Patients, 2008, 2015 &amp; 2020<\/p>\n<p style=\"text-align: justify;\">Table 5 3: Japan (Urban &amp; Rural): Total Prevalence &amp; Number of Diabetes Patients, 2008, 2015 &amp; 2020<\/p>\n<p style=\"text-align: justify;\">Table 5 4: Japan (Male &amp; Female): Total Prevalence &amp; Number of Diabetes Patients, 2008, 2015 &amp; 2020<\/p>\n<p style=\"text-align: justify;\">Table 5 5: Total Prevalence &amp; Number of Diabetes Patients by Age Group (20-39), (40-59) &amp; (60-79) (In Millions), 2008, 2015 &amp; 2020<\/p>\n<p style=\"text-align: justify;\"><strong><br \/>To buy the complete report or to get a&nbsp;free sample, please contact:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>IMARC Group Asia: <\/strong><br \/> Email:&nbsp;apac@imarcgroup.com<br \/> Phone: +91-120-415-5099&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>IMARC Group North America:<\/strong><br \/> Email: america@imarcgroup.com<br \/> Phone: +1-631-791-1145<\/p>\n<p style=\"text-align: justify;\"><strong>IMARC Group Europe, Middle East &amp; Africa:<\/strong><br \/> Email: ema@imarcgroup.com<br \/> Phone: +44-702-409-7331&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To know more please visit: <\/strong><a rel=\"nofollow\" href=\"http:\/\/www.imarcgroup.com\/japan-diabetes-market\">http:\/\/www.imarcgroup.com\/japan-diabetes-market<\/a><\/p>\n<p style=\"text-align: justify;\"><strong><br \/>About IMARC Group<\/strong><\/p>\n<p style=\"text-align: justify;\">The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.<\/p>\n<p style=\"text-align: justify;\">IMARC&rsquo;s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company&rsquo;s expertise.<\/p>\n<p style=\"text-align: justify;\"><strong>To know more about our company, please visit:<\/strong>&nbsp;<a rel=\"nofollow\" title=\"IMARC Group\" href=\"http:\/\/www.imarcgroup.com\/\" target=\"_blank\">http:\/\/www.imarcgroup.com\/<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> IMARC Group<br \/><strong>Contact Person:<\/strong> Krishna Sharma<br \/><strong>Email:<\/strong> sales@imarcgroup.com<br \/><strong>Phone:<\/strong> +91-120-415-5099<br \/><strong>Address:<\/strong>G B Nagar Noida Complex  <br \/><strong>City:<\/strong> Noida<br \/><strong>State:<\/strong> Uttar Pradesh<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.imarcgroup.com\/\" target=\"_blank\" rel=\"nofollow\">http:\/\/www.imarcgroup.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.imarcgroup.com\/\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=japan-diabetes-market-an-insight-into-the-oral-antidiabetics-insulin-and-diabetes-diagnostics-market-in-japan\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics&#8221; This new report from IMARC Group provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. This study serves as an &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/japan-diabetes-market-an-insight-into-the-oral-antidiabetics-insulin-and-diabetes-diagnostics-market-in-japan_57487.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-57487","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/57487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=57487"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/57487\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=57487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=57487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=57487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}